Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: Comparison of real-life effectiveness in the treatment of agitation

David J. Castle;  Tudor Udristoiu;  Chang Yoon Kim;  Andrea Sarosi;  Vladimir Pidrman;  A. Nasser Omar;  Juan Ignacio Rosales;  Yuval Melamed;  Turgut Isik;  Jamie Karagianis; Tamas Treuer

World Journal of Biological Psychiatry, Volume 10, Issue 1 March 2009, pages 43 - 53

 

3 - Electrocardiographical P Wave Changes After Electroconvulsive Therapy in Patients With Schizophrenia: A Preliminary Study

Bayar, Reha; Emül, Murat; Turan, Şenol; Zerdali, Hasan; Salihoglu, Tamer; Duran, Alaattin; Uğur, Müfit; Keleş, İbrahim

The Journal of ECT:Volume 25(1)March 2009pp 26-30

 

3 - Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Yu-Chih Shen, Shih-Fen Chen, Chia-Hsiang Chen, Chaucer C.H. Lin, Shaw-Ji Chen, Yu-Jung Chen and Sy-Ueng Luu

Journal of Psychiatric Research. Volume 43, Issue 6, March 2009, Pages 600-606

 

3! - Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Hong Shen, Rui Li, Hong Xiao, Qun Zhou, Qing Cui and Jianfang Chen

Journal of Psychiatric Research. Volume 43, Issue 6, March 2009, Pages 615-619

 

3! - Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Stefan Gebhardt, Michael Haberhausen, Monika Heinzel-Gutenbrunner, Nadine Gebhardt, Helmut Remschmidt, Jürgen-Christian Krieg, Johannes Hebebrand and Frank M. Theisen

Journal of Psychiatric Research. Volume 43, Issue 6, March 2009, Pages 620-626

 

3! - The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study

Pål Gjerden, Jørgen G. Bramness & Lars Slørdal

British Journal of Clinical Pharmacology. Volume 67 Issue 2, Pages 228 - 233

 

3 - Comparing the Effectiveness of Aripiprazole and Quetiapine in Schizophrenia and Related Psychoses: A Naturalistic, Retrospective Chart Review Study

Polash Shajahan, Sonia Keith, Chetan Majjiga, Jennifer Murphy, Alison MacRae, Muhammad Bashir, and Mark Taylor

J Clin Psychiatry March 10, 2009: e1-e7

 

5< - An Exploration of the Effect of Modafinil on Olanzapine Associated Weight Gain in Normal Human Subjects

References and further reading may be available for this article. To view references and further reading you must purchase this article.

James L. Roerig, Kristine J. Steffen, James E. Mitchell, Ross D. Crosby and Blake A. Gosnell

Biological Psychiatry. Volume 65, Issue 7, 1 April 2009, Pages 607-613

3 - Effects of antipsychotics and vitamin C on the formation of reactive oxygen species

P Heiser, O Sommer, AJ Schmidt, HW Clement, A Hoinkes, UT Hopt, E Schulz, JC Krieg, and E Dobschütz

Journal of Psychopharmacology. First published on March 12, 2009

 

3 - Risperidone long-acting injection: factors associated with changes in bed stay and hospitalisation in a 3-year naturalistic follow-up

D Taylor and V Cornelius

Journal of Psychopharmacology. First published on March 12, 2009

3! - Suicidal Behavior in Schizophrenia: A Test of the Demoralization Hypothesis

Restifo, Kathleen; Harkavy-Friedman, Jill M; Shrout, Patrick E

The Journal of Nervous and Mental Disease:Volume 197(3)March 2009pp 147-153

 

5 - A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia

Jeffrey A Lieberman, Kelly Papadakis, John Csernansky, Robert Litman, Jan Volavka, Xinwei Daniel Jia and Allyson Gage for the MEM-MD-29 Study Group

Neuropsychopharmacology (2009) 34, 1322–1329

 

5 - Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia

Daniel E Casey, David G Daniel, Carol Tamminga, John M Kane, Tram Tran-Johnson, Patricia Wozniak, Walid Abi-Saab, Jeff Baker, Laura Redden, Nicholas Greco and Mario Saltarelli

Neuropsychopharmacology (2009) 34, 1330–1338

 

4 - The Moderating Impact of Ethnicity on Metabolic Outcomes During Treatment With Olanzapine and Aripiprazole in Patients With Schizophrenia

Jonathan M. Meyer, Lisa C. Rosenblatt, Edward Kim, Ross A. Baker, and Richard Whitehead

J Clin Psychiatry 2009;70(3):318-325

 

3! - Increased Antipsychotic Sensitivity in Elderly Patients: Evidence and Mechanisms

Hiroyuki Uchida, David C. Mamo, Benoit H. Mulsant, Bruce G. Pollock, and Shitij Kapur

J Clin Psychiatry 2009;70(3):397-405

 

3! - Risk Factors for Violent Crime in Schizophrenia: A National Cohort Study of 13,806 Patients

Seena Fazel, Martin Grann, Eva Carlström, Paul Lichtenstein, and Niklas Långström

J Clin Psychiatry 2009;70(3):362-369

 

GRATIS 3! - A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole

Salvatore Gentile

Neuropsychiatric Disease and Treatment. February 2009

 

3 - Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Lei Wei and Lei Chen

Neuroscience Letters. Volume 454, Issue 1, 17 April 2009, Pages 49-52

 

3 - Clinical Recovery in First-Episode Psychosis

Lex Wunderink, Sjoerd Sytema, Fokko J. Nienhuis and Durk Wiersma

Schizophrenia Bulletin 2009 35(2):362-369

 

3! - Psychiatric Comorbidities and Schizophrenia

Peter F. Buckley, Brian J. Miller, Douglas S. Lehrer and David J. Castle

Schizophrenia Bulletin 2009 35(2):383-402

 

3! - Telomere Length and Pulse Pressure in Newly Diagnosed, Antipsychotic-Naive Patients With Nonaffective Psychosis

Emilio Fernandez-Egea, Miguel Bernardo, Christopher M. Heaphy, Jeffrey K. Griffith, Eduard Parellada, Enric Esmatjes, Ignacio Conget, Linh Nguyen, Varghese George, Hubert Stöppler and Brian Kirkpatrick

Schizophrenia Bulletin 2009 35(2):437-442

 

5 - Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

Christoph U. Correll, Christine Rummel-Kluge, Caroline Corves, John M. Kane and Stefan Leucht

Schizophrenia Bulletin 2009 35(2):443-457

 

5 - Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?

Corrado Barbui, Alessandra Signoretti, Serena Mulè, Marianna Boso and Andrea Cipriani

Schizophrenia Bulletin 2009 35(2):458-468

 

3 - Are depot antipsychotics more coercive than tablets?

MX Patel^*, N de Zoysa, M Bernadt, J Bindman, and AS David

Journal of Psychopharmacology First published on March 20, 2009

 

3! - The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness

RIG Holt, T Abdelrahman, M Hirsch, Z Dhesi, T George, T Blincoe, and RC Peveler

Journal of Psychopharmacology First published on March 20, 2009

5 - How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

S Leucht, D Arbter, R R Engel, W Kissling and J M Davis

Molecular Psychiatry (2009) 14, 429–447

 

3 - Relationship between Neuroleptic Extrapyramidal Syndromes and Patients' All-Cause Mortality

J. Modestin, M. Vogt Wehrli, P. L. Stephan, P. Agarwalla

Pharmacopsychiatry 2009; 42: 57-60

4 - The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: Results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Ira D. Glick, Raymond Mankoski, James M. Eudicone, Ronald N. Marcus, Quynh-Van Tran and Sheila Assunção-Talbott

Journal of Affective Disorders. Volume 115, Issues 1-2, May 2009, Pages 18-26

 

GRATIS 4 - Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis

Virginia L Stauffer, Ilya Lipkovich, Vicki Poole Hoffmann, Alexandra N Heinloth, H SCOTT McGregor and Bruce J Kinon

BMC Psychiatry 2009, 9:12

 

3 - Quetiapine Extended Release: In Schizophrenia

Baldwin, Claudine M.; Scott, Lesley J

CNS Drugs:Volume 23(3)2009pp 261-269

 

3! - The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jari Tiihonen, Kristian Wahlbeck and Vesa Kiviniemi

Schizophrenia Research. Volume 109, Issues 1-3, April 2009, Pages 10-14

 

3! - The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: A systematic review and meta analysis

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Saeed Farooq, Matthew Large, Olav Nielssen and Waquas Waheed

Schizophrenia Research. Volume 109, Issues 1-3, April 2009, Pages 15-23

 

3! - Endophenotypes in schizophrenia: A selective review
A. Allen, M. Griss, B. Folley, K. Hawkins, G. Pearlson

Schizophrenia Research, 2009; Volume 109, Issue 1, Pages 24-37

5< - A double-blind trial of adjunctive allopurinol for schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Faith B. Dickerson, Cassie R. Stallings, Andrea E. Origoni, Anne Sullens, Sunil Khushalani, Neil Sandson and Robert H. Yolken

Schizophrenia Research. Volume 109, Issues 1-3, April 2009, Pages 66-69

 

3 - Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

David C. Henderson, Xiaoduo Fan, Paul M. Copeland, Bikash Sharma, Christina P. Borba, Sharon I. Forstbauer, Kate Miley, Ryan Boxill, Oliver Freudenreich, Corrine Cather, Anne E. Evins, Donald C. Goff

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 3, Pages 225 - 232

 

5 - Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial

Michael Berk, Clarissa S. Gama, Suresh Sundram, Harry Hustig, Les Koopowitz, Russell D'Souza, Hamish Malloy, Cate Rowland, Alison Monkhouse, Andrew Monkhouse, Fiona Bole, Sumathy Sathiyamoorthy, Danijela Piskulic, Seetal Dodd

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 3, Pages 233 - 238

 

3! - Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Sung Woo Park, Jung Goo Lee, Eun Kyung Ha, Sang Mi Choi, Hye Yeon Cho, Mi Kyoung Seo and Young Hoon Kim

European Neuropsychopharmacology. Volume 19, Issue 5, May 2009, Pages 356-362

 

3 - Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism

A Mead and M Li

Journal of Psychopharmacology First published on March 27, 2009

3 - Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats

GD Cooper, AJ Goudie, and JCG Halford

Journal of Psychopharmacology First published on March 27, 2009

3! - The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of Schizophrenia

RM Abou El-Magd, HK Park, T Kawazoe, S Iwana, K Ono, SP Chung, M Miyano, K Yorita, T Sakai, and K Fukui

Journal of Psychopharmacology First published on March 27, 2009

3 - Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine

Original Investigation

Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine

Nima Davoodi, Mikhail Kalinichev, Sergei A. Korneev and Peter G. Clifton

Psychopharmacology. On Line First. December 2008

 

5 - A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

John M. Kane, Olawale Osuntokun, Ludmila A. Kryzhanovskaya, Wen Xu, Virginia L. Stauffer, Susan B. Watson, and Alan Breier

J Clin Psychiatry March 24, 2009: e1-e10

 

3! - Hormonal Markers of Metabolic Dysregulation in Patients With Severe Mental Disorders After Olanzapine Treatment Under Real-Life Conditions

Birkenaes, Astrid B; Birkeland, Kåre I; Friis, Svein; Opjordsmoen, Stein; Andreassen, Ole A

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 109-116

 

3! - Changes in Neurocognitive Function in Patients With Schizophrenia After Starting or Switching to Amisulpride in Comparison With the Normal Controls

Ahn, Yong Min; Lee, Kyu Young; Kim, Chul-Eung; Kim, Jae-Jin; Kang, Dae-Yeob; Jun, Tae-Youn; Choi, Jin Sook; Chung, In-Won; Kim, Se Hyun; Hwang, Samuel S.-H; Kim, Yong Sik

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 117-123

 

5 - Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients

Henderson, David C; Fan, Xiaoduo; Copeland, Paul M; Sharma, Bikash; Borba, Christina P; Boxill, Ryan; Freudenreich, Oliver; Cather, Corinne; Evins, A. Eden; Goff, Donald C

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 165-169

 

3! - Systematic Overview of Cochrane Reviews for Anticholinergic Effects of Antipsychotic Drugs

Ozbilen, Mehmet; Adams, Clive E

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 141-146

 

GRATIS 3 - El proceso esquizofrénico. Forma hebefrénica. Alfred Hoche

Traducción: Daniel Buschiazzo, Luis Roldán

ALCMEON, 59, año XVII, vol. 15, Nº 3, marzo de 2009

 

GRATIS 3 - El grito silencioso de la esquizofrenia: la apatía.

D. Dachesky

ALCMEON, 59, año XVII, vol. 15, Nº 3, marzo de 2009

 

GRATIS 3! - La disolución de la paradoja etiológica de la esquizofrenia

Álvaro Machado Dias, Avelino Luiz Rodrigues

ALCMEON, 59, año XVII, vol. 15, Nº 3, marzo de 2009

 

GRATIS 3 - Prolactin Levels in Olanzapine Treatment Correlate With Positive Symptoms of Schizophrenia: Results From an Open-Label, Flexible-Dose Study

Yi-Lung Chen, Ting-Sheng Cheng, and For-Wey Lung

Prim Care Companion J Clin Psychiatry. 2009; 11(1): 16–20

 

GRATIS 3! - Visual Hallucinations: Differential Diagnosis and Treatment

Ryan C. Teeple, Jason P. Caplan, and Theodore A. Stern

Prim Care Companion J Clin Psychiatry. 2009; 11(1): 26–32

 

GRATIS 3! - Review of the efficacy of placebo in comparative clinical trials between typical and atypical antipsychotics

Irismar Reis de Oliveira, Paulo Menezes Nunes, Domingos Macedo Coutinho, Eduardo Pondé de Sena

Rev Bras Psiquiatr. 2009;31(1):52-6

.

Regresar a RESÚMENES MARZO 2009